GB1366513A - Pharmaceutical compounds and compositions - Google Patents

Pharmaceutical compounds and compositions

Info

Publication number
GB1366513A
GB1366513A GB5449771A GB5449771A GB1366513A GB 1366513 A GB1366513 A GB 1366513A GB 5449771 A GB5449771 A GB 5449771A GB 5449771 A GB5449771 A GB 5449771A GB 1366513 A GB1366513 A GB 1366513A
Authority
GB
United Kingdom
Prior art keywords
compositions
pharmaceutical compounds
tryptophan
lithium
nov
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB5449771A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beecham Group PLC
Original Assignee
Beecham Group PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to BE791909D priority Critical patent/BE791909A/en
Application filed by Beecham Group PLC filed Critical Beecham Group PLC
Priority to GB5449771A priority patent/GB1366513A/en
Priority to FR7241437A priority patent/FR2160946A1/fr
Priority to NL7215921A priority patent/NL7215921A/xx
Priority to DE19722257549 priority patent/DE2257549A1/en
Publication of GB1366513A publication Critical patent/GB1366513A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/20—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals substituted additionally by nitrogen atoms, e.g. tryptophane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

1366513 Lithium tryptophan BEECHAM GROUP Ltd 22 Nov 1972 [24 Nov 1971] 54497/71 Heading C2C [Also in Division A5] Lithium tryptophan salt is prepared from lithium hydroxide and tryptophan.
GB5449771A 1971-11-24 1971-11-24 Pharmaceutical compounds and compositions Expired GB1366513A (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
BE791909D BE791909A (en) 1971-11-24 PHARMACEUTICAL COMPOSITIONS CONTAINING LITHIUM AND TRYPTOPHAN
GB5449771A GB1366513A (en) 1971-11-24 1971-11-24 Pharmaceutical compounds and compositions
FR7241437A FR2160946A1 (en) 1971-11-24 1972-11-22
NL7215921A NL7215921A (en) 1971-11-24 1972-11-23
DE19722257549 DE2257549A1 (en) 1971-11-24 1972-11-23 LITHIUM TRYPTOPHANE, THE PROCESS FOR ITS MANUFACTURING AND MEDICINAL PRODUCTS CONTAINING THIS COMPOUND

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB5449771A GB1366513A (en) 1971-11-24 1971-11-24 Pharmaceutical compounds and compositions

Publications (1)

Publication Number Publication Date
GB1366513A true GB1366513A (en) 1974-09-11

Family

ID=10471204

Family Applications (1)

Application Number Title Priority Date Filing Date
GB5449771A Expired GB1366513A (en) 1971-11-24 1971-11-24 Pharmaceutical compounds and compositions

Country Status (5)

Country Link
BE (1) BE791909A (en)
DE (1) DE2257549A1 (en)
FR (1) FR2160946A1 (en)
GB (1) GB1366513A (en)
NL (1) NL7215921A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4299838A (en) * 1974-12-23 1981-11-10 La Cooperation Pharmaceutique Francaise Tryptophan derivatives having an increased effect on the central nervous system

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4299838A (en) * 1974-12-23 1981-11-10 La Cooperation Pharmaceutique Francaise Tryptophan derivatives having an increased effect on the central nervous system

Also Published As

Publication number Publication date
NL7215921A (en) 1973-05-28
DE2257549A1 (en) 1973-05-30
FR2160946A1 (en) 1973-07-06
BE791909A (en) 1973-05-24

Similar Documents

Publication Publication Date Title
AU471246B2 (en) Improvements rela ting to shoulder surgery
GB1301973A (en)
GB1263000A (en) 4,4',4''-trihydroxytriphenylmethylmethane and process for preparing it
CA934270A (en) Vanne de detente d'un fluide sous pression
CA942310A (en) Preparation of n-substituted 6,7-methylenedioxy-4-quinolone derivatives
GB1366513A (en) Pharmaceutical compounds and compositions
GB1301555A (en)
AU465874B2 (en) Stable solutions of calcium salts
GB1132583A (en) Pharmaceutical compositions containing cephalosporins
GB1296333A (en)
GB1371693A (en) 4,6-dihydro-1,3-dimethyl-4-ethyl-8-phenylpyrazolo-4,3-e-1,4- diazepin-5-1h-one and compositions containing the same
GB1395929A (en) Thioureas
GB1479713A (en) Carboxymethyl thiols
GB1377787A (en) Aminopropanol derivatives
GB1175590A (en) Therapeutic Compositions
GB1433845A (en) Phar
AU455249B2 (en) Manufacature of 1,1'-disubstituted-4,4'-benpyridylium salts and related compounds
GB1304541A (en)
CA957441A (en) Dispositif d'epuration biologique des eaux usees
AU462640B2 (en) Preparation of 2, 2'bipyridyls
AU2482771A (en) Manufacature of 1,1'-disubstituted-4,4'-benpyridylium salts and related compounds
CA820365A (en) Preparation of substituted bicyclo-(2.2.2)oct-2-ene-1-amines
CA1020688A (en) Fireproof fibre containing 25% to 40% chlorine, and of low thermoplasticity
CA859778A (en) Addition compounds of certain sodium and lithium salts with 4,4'-methylenedianiline
CA830515A (en) Preparation of 1-n-butyl-2',6'-pipecoloxylidide

Legal Events

Date Code Title Description
PS Patent sealed
PLNP Patent lapsed through nonpayment of renewal fees